Clinical efficacy of angiotensin receptor-neprilysin inhibitor in de novo heart failure with reduced ejection fraction

Clinical efficacy of angiotensin receptor-neprilysin inhibitor in de novo heart failure with reduced ejection fraction

Background/Aims We aimed to analyze the efficacy of angiotensin receptor-neprilysin inhibitor (ARNI) by the disease course of heart failure (HF). Methods We evaluated 227 patients with HF in a multi-center retrospective cohort that included those with left ventricular ejection fraction (LVEF) ≤ 40%...

Full description

Bibliographic Details
Main Authors: Su Yeong Park, Min Gyu Kong, Inki Moon, Hyun Woo Park, Hyung-Oh Choi, Hye Sun Seo, Yoon Haeng Cho, Nae-Hee Lee, Kwan Yong Lee, Ho-Jun Jang, Je Sang Kim, Ik Jun Choi, Jon Suh
Format: Article
Language:English
Published: The Korean Association of Internal Medicine 2023-09-01
Series:The Korean Journal of Internal Medicine
Subjects:
angiotensin receptor-neprilysin inhibitor
heart failure
clinical outcome
cardiac reverse remodeling
worsening heart failure
Online Access:http://kjim.org/upload/kjim-2023-065.pdf

Internet

http://kjim.org/upload/kjim-2023-065.pdf

Similar Items